Florida Surgery & Weight Loss Center now helps eligible Medicare patients review whether they may qualify for treatment through the Medicare GLP-1 Bridge Program
The 2026 Part D out-of-pocket cap of $2,000 provides a ceiling but reaching it requires significant spending first
That includes: Appropriate use of pharmacotherapies Metabolic and bariatric surgery when indicated Lifestyle intervention as a co-therapy, not an alternative and not a pathway to deprescribing Longitudinal, patient-centered care that addresses biology, function, and quality of life Recent FDA action regarding non-FDA-approved GLP-1 products is an important reminder that safety, evidence, and oversight matter: : Access matters
At TrimRx, we are more than just a provider of medications
Glutathione and diseases of ageing
When combined with semaglutide, the gastric emptying delay is maintained but tolerability is similar to semaglutide alone